Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer

IMPORTANCE: High body mass index (BMI) is independently associated with overall survival benefit from immune checkpoint inhibitor therapy in patients with melanoma, yet whether BMI is associated with outcomes in patients with advanced non–small cell lung cancer treated with atezolizumab remains unkn...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Oncol
Autori principali: Kichenadasse, Ganessan, Miners, John O., Mangoni, Arduino A., Rowland, Andrew, Hopkins, Ashley M., Sorich, Michael J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2019
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6990855/
https://ncbi.nlm.nih.gov/pubmed/31876896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.5241
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi